Konica Minolta Precision Medicine Collaborates with AWS to Create the Next Generation of Precision Diagnostics

Tokyo (March 10, 2021)Konica Minolta Precision Medicine, Inc. (KMPM), a Konica Minolta Group company, announced today a five-year collaboration with Amazon Web Services, Inc. (AWS). As the Preferred Cloud Provider for KMPM, AWS will support the build-out of the company’s LATTICETM initiative globally. LATTICETM is a groundbreaking integrated diagnostic data platform that combines genomics, pathology, and radiology data along with other critical information to uncover new, clinically relevant biomarkers and create the next generation of diagnostic tests. As part of this collaboration, Amazon has made a financial investment in KMPM.

(more…)

TauIQ launches in Invicro’s Core Lab alongside seminal publication in the Journal of Nuclear Medicine

 

BOSTON, MA, 01 February 2021 Invicro LLC, a Konica Minolta company announces that the paper, TauIQ – A canonical image-based algorithm to quantify tau PET scans, will be published in The Journal of Nuclear Medicine (JNM). In conjunction with this publication, Invicro has launched 21 CFR Part 11 compliant TauIQ services in its Core Lab as part of its expanded IQ-Analytics Platform, which includes AmyloidIQ and DaTIQ.

(more…)

Konica Minolta Precision Medicine, Inc. Acquires Backpack Health Assets

Aliso Viejo, CA (20 May 2020), Konica Minolta Precision Medicine, Inc. (KMPM), a subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the acquisition of the assets of Backpack Health (BPH), a secure mobile and web-based health data management platform.

(more…)

Invicro LLC to Establish a Repository of Medical Image Datasets for COVID-19 Research

 

BOSTON, MA (5 May 2020), Invicro LLC, is working with Microsoft to create a free repository of COVID-19 diagnostic CT and X-ray datasets to facilitate understanding and treating this global threat. The repository uses the advanced technologies in Invicro’s iPACS® and the Microsoft Azure cloud platform, offering the required security, privacy, and compute power. This critical mission invites and strongly encourages researchers worldwide to access the data and to contribute COVID-19 images and clinical data.

(more…)

Invicro Collaborates with Yale’s, Dr. David Rimm to Expand the Utility of Quanticell™ for Clinical Pathology Applications

 

BOSTON, MA March 9, 2020, Invicro LLC, a Konica Minolta Company announced it has entered into a strategic research partnership with industry leading pathologist, Dr. David Rimm, MD, PhD, at The Yale University School of Medicine to advance the development of Quanticell, Konica Minolta’s propriety tissue biomarker detection technology.

(more…)

Invicro Scientists Work on Imaging Synaptic Density in Schizophrenia Published in Nature Communications

(BOSTON, MA) 28 January 2020 — Invicro LLC, a Konica Minolta Company announces that the paper “Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients and Unaffected by Antipsychotics in Rats1” has been published in Nature Communications. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development.
(more…)

Invicro and Paige Partner to Offer Comprehensive Tissue Biomarker Profiling Services

(BOSTON, MA and NEW YORK, NY) January 14, 2020 — Invicro LLC, a Konica Minolta Company and Paige, Inc., the leader in computational pathology, today announced a strategic alliance to provide integrated pathology solutions to support Pharmaceutical and Biotechnology sponsors with their drug discovery and development initiatives. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development. Paige is a pioneer in transforming the diagnosis and treatment of cancer through clinical-grade artificial intelligence (AI).
(more…)

Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine

(BOSTON, MA) December 23, 2019 — Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief Executive Officer. Dr. Silva will assume the day-to-day leadership responsibilities of the Company and will join Invicro’s Board of Directors, effective immediately. Dr. Jack Hoppin, co-founder of Invicro, will move on from his role as Invicro’s CEO to be the President of Konica Minolta Precision Medicine (KMPM). Dr. Hoppin will remain on Invicro’s Board of Directors, as well as continue to serve on the KMPM Board.
(more…)

Invicro Supports the Alzheimer’s Disease Neuroimaging Initiative

(BOSTON, MA) December 11, 2019 — Invicro LLC, a Konica Minolta Company, today announced funding support for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and two of their distinguished scientists within the Alzheimer’s biomarkers space, Drs. Roger Gunn and Kenneth Marek, will join the ADNI-Private Partner Scientific Board (PPSB). Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development.

(more…)

Invicro LLC Joins Accenture’s INTIENT™ Network to Help Advance Innovation in Drug Discovery and Scientific Research

(BOSTON, MA) December 3, 2019 — Today, Invicro LLC, a Konica Minolta Company, has joined Accenture’s open partner ecosystem—the INTIENT™ Network—which is designed to help solution providers, software vendors and life sciences companies’ team more effectively to accelerate drug discovery and improve patient outcomes. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for drug discovery and development.

(more…)